Breaking News Instant updates and real-time market news.

2021-02-22 07:26:07 MAR Marriott / + 07:26 02/22/21 02/22 07:26 02/22/21 07:26	Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform As previously reported, Evercore ISI analyst Rich Hightower upgraded Marriott to Outperform from In Line with a price target of $158, up from $150, as he updated his models for lodging C-Corps following earnings last week from the group. While hotel stocks in general have benefited significantly from the "re-opening trade" over the past 90 or so days, Marriott shares have lagged direct peers over the past 30, 90, and 365 days, noted Hightower, who now views the stock as the best "value play" within his lodging coverage in terms of both REITs and C-Corps.
MAR Marriott / + 02/22/21 Evercore ISI Marriott upgraded to Outperform from In Line at Evercore ISI 02/19/21 Deutsche Bank Marriott price target raised to $135 from $96 at Deutsche Bank 01/05/21 Gordon Haskett Marriott price target raised to $125 from $108 at Gordon Haskett 12/15/20 Citi Marriott upgraded to Buy from Neutral at Citi

2021-02-22 07:26:07

MAR

Marriott

/ +

07:26

02/22/21

02/22

07:26

02/22/21

07:26

Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform

As previously reported, Evercore ISI analyst Rich Hightower upgraded Marriott to Outperform from In Line with a price target of $158, up from $150, as he updated his models for lodging C-Corps following earnings last week from the group. While hotel stocks in general have benefited significantly from the "re-opening trade" over the past 90 or so days, Marriott shares have lagged direct peers over the past 30, 90, and 365 days, noted Hightower, who now views the stock as the best "value play" within his lodging coverage in terms of both REITs and C-Corps.

MAR Marriott

/ +

02/22/21 Evercore ISI: Marriott upgraded to Outperform from In Line at Evercore ISI

02/19/21 Deutsche Bank: Marriott price target raised to $135 from $96 at Deutsche Bank

01/05/21 Gordon Haskett: Marriott price target raised to $125 from $108 at Gordon Haskett

12/15/20 Citi: Marriott upgraded to Buy from Neutral at Citi

TODAY'S FREE FLY STORIES

Recommendations	ChemoCentryx price target raised to $101 from $83 at H.C. Wainwright » 06:15 03/02/21 03/02 06:15 03/02/21 06:15 CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 02/24/21 ChemoCentryx appoints Tausif Butt as EVP, COO 02/17/21 ChemoCentryx ADVOCATE ph.3 study of avacopan meets both endpoints 12/29/20 ChemoCentryx director sells 25K shares of common stock 12/21/20 ChemoCentryx provides topline results from ACCOLADE trial of avacopan CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 03/01/21 Stifel ChemoCentryx initiated with a Buy at Stifel 12/22/20 Piper Sandler Piper names ChemoCentryx a top pick for 2021, boosts target to $80 11/03/20 Piper Sandler Piper confident in U.S. and EU approvals for ChemoCentryx's avacopan 10/29/20 Fly Intel: Top five analyst downgrades CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 03/01/21 ChemoCentryx reports Q4 EPS (43c), consensus (33c) 11/09/20 ChemoCentryx reports Q3 EPS (35c), consensus (31c) 11 Jun CCXI ChemoCentryx $68.79 / +0.89 (+1.31%) 12/21/20 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers 07/07/21 PDUFA Date for Avacopan
Downgrade	Athenex downgraded to Perform from Outperform at Oppenheimer » 06:14 03/02/21 03/02 06:14 03/02/21 06:14 ATNX Athenex $5.47 / -6.715 (-55.11%) Oppenheimer downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex trading resumes 03/01/21 Athenex expects cash to fund operations into 2Q22 03/01/21 Athenex announces key anticipated future milestones 03/01/21 FDA requests new study from Athenex for oral paclitaxel plus encequidar ATNX Athenex $5.47 / -6.715 (-55.11%) 05:37 Today Truist Athenex downgraded to Hold from Buy at Truist 03/01/21 JPMorgan JPMorgan downgrades Athenex on 'huge surprise' from FDA 03/01/21 SVB Leerink Athenex downgraded to Market Perform from Outperform at SVB Leerink 03/01/21 JPMorgan Athenex downgraded to Neutral from Overweight at JPMorgan ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Athenex reports Q4 adjusted EPS (43c), consensus (44c) 11/05/20 Athenex sees 2020 y-o-y product sales growth in low twenties percentage growth 11/05/20 Athenex reports Q3 EPS (44c), consensus (43c) 10 Sep ATNX Athenex $5.47 / -6.715 (-55.11%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers
Hot Stocks	CareTrust REIT acquires four California CCRCs in Southern California » 06:13 03/02/21 03/02 06:13 03/02/21 06:13 CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) , MAR Marriott $148.22 / +0.11 (+0.07%) CareTrust REIT (CTRE)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 12/17/20 CareTrust REIT reports Q4 collections of 99.7% 11/17/20 CareTrust REIT acquires four post-acute care facilities in Texas for $47.6M 09/02/20 CareTrust REIT expands in Montana MAR Marriott $148.22 / +0.11 (+0.07%) 02/25/21 Marriott CFO sells 25K shares of common stock 02/23/21 Marriott names Anthony Capuano as new CEO 02/23/21 Marriott names Anthony Capuano as new CEO 02/18/21 Marriott: Hotel owners sticking to payment plans CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 01/19/21 Barclays CareTrust REIT price target raised to $25 from $21 at Barclays 01/13/21 Mizuho CareTrust REIT price target raised to $22 from $19 at Mizuho 01/07/21 BMO Capital CareTrust REIT upgraded to Outperform from Market Perform at BMO Capital 12/14/20 KeyBanc CareTrust REIT upgraded to Overweight from Sector Weight at KeyBanc MAR Marriott $148.22 / +0.11 (+0.07%) 02/24/21 Stifel American Airlines price target raised to $20 from $14 at Stifel 02/22/21 Wells Fargo Marriott price target raised to $154 from $147 at Wells Fargo 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/22/21 Evercore ISI Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform CTRE MAR CTRE CareTrust REIT $22.82 / +0.59 (+2.65%) 02/10/21 CareTrust REIT sees FY21 normalized FFO $1.40-$1.42, consensus $1.45 02/10/21 CareTrust REIT reports Q4 normalized FFO 36c, consensus 36c MAR Marriott $148.22 / +0.11 (+0.07%) 02/18/21 Marriott reports Q4 adjusted EPS 12c, consensus 11c 02/17/21 Notable companies reporting before tomorrow's open 02/17/21 Notable companies reporting before tomorrow's open 11/06/20 Marriott reports Q3 adjusted EPS 6c, consensus (8c) MAR MAR Marriott $148.22 / +0.11 (+0.07%) 02/17/21 Linnartz, Capuano seen as frontrunners for Marriott CEO role, WSJ reports 01/11/21 JPMorgan, Citi to halt all PAC donations, WSJ reports 01/10/21 Marriott suspends donations to Senators who opposed vote result, Bloomberg says 12/15/20 Marriott permanently cuts over 800 jobs at Times Square hotel, NY Post says MAR MAR Marriott $148.22 / +0.11 (+0.07%) 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 11/19/20 Target, Shopify upgrades among today's top calls on Wall Street 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/06/20 Fly Intel: Pre-market Movers MAR MAR Marriott $148.22 / +0.11 (+0.07%) 12/29/20 Early notable gainers among liquid option names on December 29th 12/21/20 Marriott put volume heavy and directionally bearish 11/12/20 Marriott put volume heavy and directionally bearish 10/26/20 Marriott put volume heavy and directionally bearish
Recommendations	Chiasma price target raised to $12 from $10 at H.C. Wainwright » 06:13 03/02/21 03/02 06:13 03/02/21 06:13 CHMA Chiasma $3.95 / +0.055 (+1.41%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CHMA Chiasma $3.95 / +0.055 (+1.41%) 01/19/21 Chiasma appoints John Doyle as CFO 01/06/21 Chiasma provides update, sees FY21 operating expenses $80M-90M 11/20/20 Chiasma to host panel on acromegaly, MPOWERED Phase 3 trial results 11/18/20 Chiasma says MPOWERED Phase 3 trial met primary non-inferiority endpoint CHMA Chiasma $3.95 / +0.055 (+1.41%) 01/11/21 Piper Sandler Chiasma price target lowered to $15 from $19 at Piper Sandler 11/05/20 Piper Sandler Chiasma reports first Mycapssa sales, strong cash balance, says Piper Sandler 08/31/20 Piper Sandler Piper sees strong demand for Chiasma's oral acromegaly therapy 08/13/20 Jefferies Chiasma initiated with a Buy at Jefferies CHMA Chiasma $3.95 / +0.055 (+1.41%) 11/05/20 Chiasma reports Q3 EPS (30c), consensus (39c) 01 Jul 03/04/21 Chiasma - CHMA
Recommendations	Procter & Gamble removed from the US 1 List at BofA 06:12 03/02/21 03/02 06:12 03/02/21 06:12 PG Procter & Gamble $124.25 / +0.75 (+0.61%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PG Procter & Gamble $124.25 / +0.75 (+0.61%) 02/12/21 Trian Fund exits nVent, increases stake in GE 01/22/21 Procter & Gamble licenses nasal swab to Rhinostics for Covid test 01/21/21 Cerner appoints Marck Erceg as CFO 01/20/21 Procter & Gamble says innovating, bringing new products to market PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/28/21 Stifel Stifel downgrades Procter & Gamble to Hold on emerging headwinds 01/28/21 Stifel Procter & Gamble downgraded to Hold from Buy at Stifel 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/20/21 Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 01/20/21 Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open PG Procter & Gamble $124.25 / +0.75 (+0.61%) 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports 10/13/20 P&G investors approve proposal for deforestation report, Bloomberg says PG Procter & Gamble $124.25 / +0.75 (+0.61%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street PG Procter & Gamble $124.25 / +0.75 (+0.61%) 02/26/21 Unusually active option classes on open February 26th 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th

Periodicals	Tailored Brands nears $75M loan after bankruptcy exit, WSJ reports » 06:12 03/02/21 03/02 06:12 03/02/21 06:12 TLRD Tailored Brands $0.00 / + (+0.00%) Tailored Brands Inc., the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TLRD Tailored Brands $0.00 / + (+0.00%) 12/02/20 Tailored Brands completes financial restructuring, emerges from Chapter 11 TLRD Tailored Brands $0.00 / + (+0.00%) 03/19/20 Deutsche Bank Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
Recommendations	Dentsply Sirona price target raised to $60 from $55 at H.C. Wainwright » 06:11 03/02/21 03/02 06:11 03/02/21 06:11 XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 01/04/21 Dentsply Sirona acquires Byte in $1.04B all-cash deal 01/04/21 Dentsply Sirona acquires Byte in $1.04B all cash deal XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Piper Sandler Dentsply Sirona price target raised to $70 from $63 at Piper Sandler 02/09/21 Stifel Dentsply Sirona checks point to potential channel conflict, says Stifel 01/08/21 Credit Suisse Envista upgraded to Outperform from Neutral at Credit Suisse 01/05/21 Baird Dentsply Sirona price target raised to $62 from $58 at Baird XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Dentsply Sirona sees FY21 adjusted EPS $2.60-$2.80, consensus $2.39 03/01/21 Dentsply Sirona reports Q4 adjusted EPS 87c, consensus 64c 11/05/20 Dentsply Sirona reports Q3 non-GAAP EPS 67c, consensus 32c 11/04/20 Notable companies reporting before tomorrow's open XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Fly Intel: Pre-market Movers 11/05/20 Fly Intel: Pre-market Movers XRAY Dentsply Sirona $59.71 / +6.71 (+12.66%) 03/01/21 Early notable gainers among liquid option names on March 1st 10/22/20 Early notable gainers among liquid option names on October 22nd
Initiation	Darling Ingredients initiated with an Overweight at Piper Sandler » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 DAR Darling Ingredients $64.07 / +1.005 (+1.59%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 01/28/21 Darling Ingredients, Valero joint venture receives approval for Texas facility 10/27/20 Darling Ingredients' joint venture receives air permit from TCEQ DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 01/29/21 Baird Darling Ingredients price target raised to $71 from $50 at Baird 01/27/21 JPMorgan Darling Ingredients price target raised to $69 from $48 at JPMorgan 11/05/20 BMO Capital Darling Ingredients price target raised to $46 from $33 at BMO Capital 10/22/20 Roth Capital Darling Ingredients price target raised to $84 from $38 at Roth Capital DAR Darling Ingredients $64.07 / +1.005 (+1.59%) 11/03/20 Darling Ingredients reports Q3 GAAP EPS 61c, consensus 44c 03/15/21 33rd Annual Roth Virtual Conference 03/18/21 Waste & Environmental Services Virtual Symposium 03/03/21 Darling Ingredients - DAR
Hot Stocks	Kaixin Auto announces Haitaoche's subsidiaries new vehicle sales contracts » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) Kaixin Auto Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Options KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 01/11/21 Kaixin Auto: Haitaoche enters five-year vehicles supply contract with CVC 01/04/21 Kaixin Auto enters share purchase agreement with Haitaoche shareholders 11/05/20 Kaixin Auto CEO Chen Ji, COO Jinfeng Xie resign from positions 11/05/20 Kaixin Auto enters binding term sheet for Haitaoche merger KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 11/05/20 Fly Intel: Wall Street's top stories at midday 11/05/20 Fly Intel: Pre-market Movers KXIN Kaixin Auto $3.49 / +0.11 (+3.25%) 11/16/20 Sixteen new option listings and one option delisting on November 16th
Periodicals	Frontier Airlines cancels flight after passengers refuse to wear masks, NYT says » 06:10 03/02/21 03/02 06:10 03/02/21 06:10 FRNTQ Frontier Airlines $0.00 / + (+0.00%) Frontier Airlines… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Recommendations	F5 Networks price target raised to $223 from $216 at Piper Sandler » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 FFIV F5 Networks $194.05 / +3.92 (+2.06%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FFIV F5 Networks $194.05 / +3.92 (+2.06%) 02/16/21 Elliott buys Evergy, exits eBay in Q4 01/07/21 F5 Networks jumps 3% to $186 after confirming Volterra acquisition 01/07/21 F5 Networks raises long-term revenue growth view to double digits 01/07/21 F5 Networks confirms $500M acquisition of Volterra FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/27/21 RBC Capital F5 Networks price target raised to $200 from $182 at RBC Capital 01/27/21 Piper Sandler F5 Networks price target raised to $216 from $205 at Piper Sandler 01/25/21 Cowen F5 Networks price target raised to $255 from $223 at Cowen 01/14/21 Barclays F5 Networks price target raised to $235 from $212 at Barclays FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/26/21 F5 Networks sees Q2 adjusted EPS $2.32-$2.44, consensus $2.41 01/26/21 F5 Networks reports Q1 adjusted $2.59, consensus $2.46 01/07/21 F5 Networks sees Q1 EPS above top end of prior $2.26-$2.38, consensus $2.34 10/26/20 F5 Networks sees Q1 adjusted EPS $2.26-$2.38, consensus $2.28 FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/07/21 F5 Networks near deal to buy Volterra for $500M, Bloomberg says 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says 11/08/20 Elliot Management takes stakes in F5 Networks, WSJ reports FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/26/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: After-Hours Movers 03/11/21 F5 Networks Inc. FFIV F5 Networks $194.05 / +3.92 (+2.06%) 01/08/21 Early notable gainers among liquid option names on January 8th 10/27/20 Early notable gainers among liquid option names on October 27th
Hot Stocks	Yatsen to acquire Eve Lom from Manzanita Capital, terms undisclosed » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 YSG Yatsen $18.63 / +1.055 (+6.00%) Yatsen announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options YSG Yatsen $18.63 / +1.055 (+6.00%) 12/29/20 Yatsen and Sensient enter into a strategic collaboration 11/30/20 Tiger Global reports 6.6% passive stake in Yatsen YSG Yatsen $18.63 / +1.055 (+6.00%) 12/14/20 Morgan Stanley Yatsen initiated with an Equal Weight at Morgan Stanley 12/13/20 Goldman Sachs Yatsen initiated with a Neutral at Goldman Sachs YSG Yatsen $18.63 / +1.055 (+6.00%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 19 Nov YSG Yatsen $18.63 / +1.055 (+6.00%) 11/22/20 Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO YSG Yatsen $18.63 / +1.055 (+6.00%) 12/16/20 Eight new option listings and one option delisting on December 16th
Upgrade	Hims & Hers upgraded to Buy from Neutral at Citi » 06:09 03/02/21 03/02 06:09 03/02/21 06:09 HIMS Hims & Hers $15.26 / +0.65 (+4.45%) Citi analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events Options HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/24/21 Hims & Hers falls -9.4% 02/01/21 Conversion Labs up 15% after Citron discloses long position 01/28/21 Hims & Hers rises 24.0% 01/28/21 Hims & Hers rises 30.6% HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/17/21 Citi Hims & Hers initiated with a Neutral at Citi 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 Piper Sandler Hims & Hers initiated with a Neutral at Piper Sandler 02/08/21 Tigress Financial Hims & Hers initiated with a Buy at Tigress Financial HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 02/01/21 Citron long Conversion Labs, says 'would be at $140' with Hims & Hers' multiple 01/12/21 A-Rod and J-Lo investors in SPAC target Hims & Hers, Sportico says 03/24/21 Hims & Hers HIMS Hims & Hers $15.26 / +0.65 (+4.45%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Initiation	Angion Biomedica initiated with an Outperform at Cowen » 06:08 03/02/21 03/02 06:08 03/02/21 06:08 ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) Cowen analyst Marc Frahm… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) 03/01/21 H.C. Wainwright Angion Biomedica initiated with a Buy at H.C. Wainwright 05 Feb ANGN Angion Biomedica $19.85 / +2.6 (+15.07%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Recommendations	Splunk may see 'slight upside' in Q4 results, says RBC Capital » 06:08 03/02/21 03/02 06:08 03/02/21 06:08 SPLK Splunk $151.21 / +8.2 (+5.73%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPLK Splunk $151.21 / +8.2 (+5.73%) 02/08/21 Splunk, McLaren Racing announce multi-year formula 1 partnership extension 12/02/20 Splunk CFO says close rates for several large deal slowed in final weeks of Q3 12/02/20 Splunk extends afterhours decline to 17% after pulling medium-term targets 12/02/20 Splunk falls 10.9% to $183.41 after downbeat Q3 results SPLK Splunk $151.21 / +8.2 (+5.73%) 02/24/21 Jefferies Jefferies remains a buyer of Splunk, sees 'favorable set-up' into earnings 02/17/21 Mizuho Splunk price target raised to $190 from $180 at Mizuho 02/11/21 Oppenheimer Splunk assumed with an Outperform at Oppenheimer 01/21/21 Goldman Sachs Splunk assumed with a Buy at Goldman Sachs SPLK Splunk $151.21 / +8.2 (+5.73%) 12/02/20 Splunk withdrawing FY23 ARR and operating cash flow targets 12/02/20 Splunk sees Q4 revenue $650M-$700M, consensus $777.73M 12/02/20 Splunk reports Q3 EPS ($1.26), consensus 9c 12/02/20 Notable companies reporting after market close SPLK Splunk $151.21 / +8.2 (+5.73%) 11/03/20 UK government in talks with Palantir about 'test-and-trace' program, FT says SPLK Splunk $151.21 / +8.2 (+5.73%) 12/29/20 Splunk initiation, Snap target change among today's top calls on Wall Street 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday 12/03/20 Splunk dives, Wall Street analysts flee after 'disappointing' earnings, outlook 03/03/21 Splunk - SPLK SPLK Splunk $151.21 / +8.2 (+5.73%) 12/23/20 Splunk call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/21/20 Splunk call volume above normal and directionally bullish 12/07/20 Unusually active option classes on open December 7th

Hot Stocks	Axonics enters strategic alliance with Micro Systems Technologies » 06:07 03/02/21 03/02 06:07 03/02/21 06:07 AXNX Axonics $53.37 / +2.98 (+5.91%) Axonics announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AXNX Axonics $53.37 / +2.98 (+5.91%) 02/25/21 Axonics to acquire Bulkamid for $200M 02/16/21 Axonics receives PMA supplement approval from FDA for its INS 11/10/20 Axonics publishes fecal incontinence study results 10/29/20 Axonics submits PMA supplement to FDA to expand MRI labeling AXNX Axonics $53.37 / +2.98 (+5.91%) 01/26/21 Baird Axonics price target raised to $65 from $58 at Baird 01/26/21 Piper Sandler Axonics price target raised to $64 from $57 at Piper Sandler 01/07/21 Morgan Stanley Axonics price target raised to $58 from $53 at Morgan Stanley 12/01/20 BofA ShockWave Medical downgraded to Neutral from Buy at BofA AXNX Axonics $53.37 / +2.98 (+5.91%) 02/25/21 Axonics reports Q4 EPS (29c), consensus (31c) 01/25/21 Axonics sees Q4 revenue $34.7M-$34.9M, consensus $35.48M 11/04/20 Axonics reports Q3 EPS (24c), consensus (50c) 08 May AXNX Axonics $53.37 / +2.98 (+5.91%) 11/04/20 Fly Intel: After-Hours Movers
Upgrade	Enable Midstream upgraded to Equal Weight from Underweight at Barclays » 06:07 03/02/21 03/02 06:07 03/02/21 06:07 ENBL Enable Midstream $6.85 / +0.25 (+3.79%) , ET Energy Transfer LP $8.13 / +0.5 (+6.55%) Barclays analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ENBL ET ENBL Enable Midstream $6.85 / +0.25 (+3.79%) 02/17/21 CenterPoint Energy supports merger of Enable Midstream, Energy Transfer LP 02/17/21 Energy Transfer LP to acquire Enable Midstream in $7.2B all-equity transaction 02/17/21 Energy Transfer LP to acquire Enable Midstream in $7B all-equity transaction 11/05/20 CenterPoint Energy continuing to evaluate Enable options ET Energy Transfer LP $8.13 / +0.5 (+6.55%) 02/17/21 CenterPoint Energy supports merger of Enable Midstream, Energy Transfer LP 02/17/21 Energy Transfer LP to acquire Enable Midstream in $7.2B all-equity transaction 02/17/21 Energy Transfer LP to acquire Enable Midstream in $7B all-equity transaction 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 ENBL ET ENBL Enable Midstream $6.85 / +0.25 (+3.79%) 03/01/21 Mizuho Enable Midstream downgraded to Neutral from Buy at Mizuho 11/16/20 Mizuho OGE Energy downgraded to Neutral on valuation at Mizuho 10/26/20 Mizuho CenterPoint Energy price target raised to $25 from $20 at Mizuho 10/15/20 Wells Fargo OGE Energy upgraded to Overweight at Wells Fargo ET Energy Transfer LP $8.13 / +0.5 (+6.55%) 03/01/21 Mizuho Enable Midstream downgraded to Neutral from Buy at Mizuho 02/25/21 UBS UBS names Energy Transfer LP to Top Picks, raises price target raised to $16 02/22/21 Piper Sandler Energy Transfer LP upgraded to Overweight from Neutral at Piper Sandler 01/12/21 Barclays Energy Transfer LP upgraded to Overweight from Equal Weight at Barclays ENBL ET ENBL Enable Midstream $6.85 / +0.25 (+3.79%) 02/24/21 Enable Midstream reports Q4 EPS 19c, consensus 13c 11/04/20 Enable Midstream updates 2020 outlook 11/04/20 Enable Midstream reports Q3 EPS (40c), consensus 15c ET Energy Transfer LP $8.13 / +0.5 (+6.55%) 02/17/21 Energy Transfer LP sees 2021 adjusted EBITDA $10.6B-$11.0B 02/17/21 Energy Transfer LP reports Q4 EPS 19c, consensus 26c 11/04/20 Energy Transfer reports Q3 EPS (29c), consensus 24c ENBL ET ENBL Enable Midstream $6.85 / +0.25 (+3.79%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday ET Energy Transfer LP $8.13 / +0.5 (+6.55%) 02/17/21 Fly Intel: Wall Street's top stories for Wednesday 02/17/21 Fly Intel: Wall Street's top stories at midday ET ET Energy Transfer LP $8.13 / +0.5 (+6.55%) 02/25/21 Energy Transfer call volume above normal and directionally bullish 02/24/21 Energy Transfer call volume above normal and directionally bullish 01/29/21 Unusually active option classes on open January 29th 01/26/21 Energy Transfer call volume above normal and directionally bullish
Hot Stocks	McDonald's CEO vows to crack down on sexual harassment in the workplace » 06:07 03/02/21 03/02 06:07 03/02/21 06:07 MCD McDonald's $208.25 / +2.1 (+1.02%) McDonald's CEO Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCD McDonald's $208.25 / +2.1 (+1.02%) 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's 01/28/21 McDonald's sees FY21 system wide sales growth of low double digits 01/28/21 McDonald's says COVID restrictions have continued into 2021 MCD McDonald's $208.25 / +2.1 (+1.02%) 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/01/21 Citi Citi opens 'Catalyst Watch' on McDonald's into chicken sandwich launch 01/21/21 UBS UBS sees 'golden' risk reward for McDonald's 01/19/21 Goldman Sachs McDonald's initiated with a Buy at Goldman Sachs MCD McDonald's $208.25 / +2.1 (+1.02%) 01/28/21 McDonald's reports Q4 non-GAAP EPS $1.70, consensus $1.78 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 MCD McDonald's $208.25 / +2.1 (+1.02%) 02/28/21 McDonald's considering selling part of Dynamic Yield, Bloomberg reports 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/09/21 Burger King testing loyalty program in five U.S. markets, CNBC reports 02/02/21 Judge rejects former McDonald's CEO's bid to dismiss lawsuit, Reuters reports MCD McDonald's $208.25 / +2.1 (+1.02%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: What to watch in Beyond Meat earnings report 01/27/21 Fly Intel: What to watch in McDonald's earnings report MCD McDonald's $208.25 / +2.1 (+1.02%) 09/09/20 Unusually active option classes on open September 9th 09/02/20 McDonald's call volume above normal and directionally bullish
Upgrade	Zoom Video upgraded to Overweight from Neutral at Piper Sandler » 06:07 03/02/21 03/02 06:07 03/02/21 06:07 ZM Zoom Video $409.67 / +35.805 (+9.58%) Piper Sandler analyst… Piper Sandler analyst James Fish upgraded Zoom Video Communications to Overweight from Neutral with a price target of $541, up from $501. The company reported a "very strong" end to fiscal 2021 and "better than feared" initial fiscal 2022 guidance, with Zoom Phone adoption and continued wins in Meetings both contributing to the upside, Fish tells investors in a research note. The analyst sees "multiple secular tailwinds behind the business." ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates 03/01/21 Lumen announces launch of Zoom Phone 02/03/21 Zoom Video announces availability of Zoom Rooms innovations 01/26/21 User reports indicate Zoom Video experiencing issues, says DownDetector ZM Zoom Video $409.67 / +35.805 (+9.58%) 01/26/21 MKM Partners Fiverr downgraded to Sell from Neutral at MKM Partners 01/13/21 Stifel Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity 01/13/21 Morgan Stanley Investors have turned too negative on Zoom's persistence, says Morgan Stanley 12/24/20 DA Davidson DA Davidson likes Zoom push into email, says buy on recent selloff ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96 03/01/21 Zoom Video sees Q1 EPS 95c-97c, consensus 72c 03/01/21 Zoom Video reports Q4 EPS $1.22, consensus 79c 03/01/21 Notable companies reporting after market close 13 Jan ZM Zoom Video $409.67 / +35.805 (+9.58%) 12/23/20 Zoom Video developing web email service, Information reports 11/13/20 NYC mayor warns parents to plan for school shutdown, Bloomberg reports 11/10/20 Microsoft wants to demolish video-conferencing competition, BI reports 10/14/20 Zoom's Yuan says won't develop chat service to rival Slack, Bloomberg reports ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Zoom Video earnings report 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Pre-market Movers ZM Zoom Video $409.67 / +35.805 (+9.58%) 03/01/21 Zoom Video Communications options imply 15.8% move in share price post-earnings 02/05/21 Zoom Video Communications call volume above normal and directionally bullish 01/15/21 Zoom Video Communications call volume above normal and directionally bullish 01/12/21 Zoom Video Communications call volume above normal and directionally bullish
Hot Stocks	X Financial to invest $10M in Dragonfly Ventures II VC fund » 06:06 03/02/21 03/02 06:06 03/02/21 06:06 XYF X Financial $3.46 / +0.08 (+2.37%) X Financial announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News XYF X Financial $3.46 / +0.08 (+2.37%) 02/08/21 X Financial rises 23.4% 12/03/20 X Financial regains compliance with NYSE

Earnings	KVH Industries reports Q4 non-GAAP EPS 7c, consensus 2c » 06:06 03/02/21 03/02 06:06 03/02/21 06:06 KVHI KVH Industries $14.15 / +0.37 (+2.69%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events KVHI KVH Industries $14.15 / +0.37 (+2.69%) 01/19/21 KVH Industries partners with GreenSteam for KVH Watch maritime IoT solution 12/17/20 KVH Industries partners with ioCurrents for KVH Watch maritime IoT solution 12/10/20 KVH Industries expands mini-VSAT Broadband HTS network coverage 09/17/20 KVH Industries CFO Reilly to retire later this year KVHI KVH Industries $14.15 / +0.37 (+2.69%) 10/29/20 KVH Industries reports Q3 adj. cont. ops. EPS 6c, consensus (17c) 09:00 Today KVH Industries - KVHI
Hot Stocks	Oyster Point Pharma says FDA accepts NDA for OC-01 (varenicline) nasal spray » 06:06 03/02/21 03/02 06:06 03/02/21 06:06 OYST Oyster Point Pharma $19.76 / -0.07 (-0.35%) Oyster Point Pharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OYST Oyster Point Pharma $19.76 / -0.07 (-0.35%) 12/18/20 Oyster Point Pharma submits NDA for OC-01 nasal spray 12/07/20 Oyster Point Pharma appoints Marian Macsai as CMO, Eric Carlson as CSO 12/01/20 Oyster Point Pharma submits OC-01 nasal spray trial protocol to FDA 11/13/20 Oyster Point presents data from Phase 2 IMPERIAL trial of OC-01 nasal spray OYST Oyster Point Pharma $19.76 / -0.07 (-0.35%) 08/05/20 Piper Sandler Oyster Point Pharma remains 'fundamentally undervalued,' says Piper Sandler 05/13/20 H.C. Wainwright H.C. Wainwright reiterates Buy on Kala after 'underwhelming' competitor data 05/11/20 Piper Sandler Piper says Oyster Point 'highly likely' to get dry eye approval, superior label 03/30/20 Piper Sandler Oyster Point ONSET-2 trial barely impacted by COVID-19, says Piper Sandler OYST Oyster Point Pharma $19.76 / -0.07 (-0.35%) 02/18/21 Oyster Point Pharma reports Q4 EPS (86c), consensus (79c) 11/05/20 Oyster Point Pharma reports Q3 EPS (63c), consensus (74c) 15 May 00:00 Today 41st Annual Healthcare Virtual Conference
Upgrade	Bank of Nova Scotia upgraded to Outperformer from Neutral at CIBC » 06:05 03/02/21 03/02 06:05 03/02/21 06:05 BNS Bank of Nova Scotia $59.74 / +1.365 (+2.34%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BNS Bank of Nova Scotia $59.74 / +1.365 (+2.34%) 02/25/21 Desjardins Bank of Nova Scotia price target raised to C$79 from C$72 at Desjardins 02/24/21 Canaccord Bank of Nova Scotia price target raised to C$77 from C$70.50 at Canaccord 02/24/21 BMO Capital Bank of Nova Scotia price target raised to C$80 from C$75 at BMO Capital 02/24/21 National Bank Bank of Nova Scotia price target raised to C$77 from C$70 at National Bank
Downgrade	Royal Bank of Canada downgraded to Neutral from Buy at BofA » 06:05 03/02/21 03/02 06:05 03/02/21 06:05 RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) BofA downgraded Royal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 02/24/21 Royal Bank of Canada reports Q1 ROE of 18.6%, up 100 bps y/y 01/28/21 Alliance Data: Bread announces technology partnership with Royal Bank of Canada 12/04/20 RBC now accepting applications for Canada's expanded CEBA loan program 12/02/20 Royal Bank of Canada reports Q4 CET1 ratio 12.5%, up 40 bps vs. last year RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 03/01/21 Argus Royal Bank of Canada price target raised to $100 from $92 at Argus 02/26/21 Desjardins Royal Bank of Canada price target raised to C$119 from C$117 at Desjardins 02/25/21 Canaccord Royal Bank of Canada price target raised to C$123 from C$116 at Canaccord 02/25/21 BMO Capital Royal Bank of Canada price target raised to C$120 from C$111 at BMO Capital RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 02/24/21 Royal Bank of Canada reports Q1 diluted EPS C$2.66, up 11% y/y 12/02/20 Royal Bank of Canada reports Q4 diluted EPS C$2.23 vs. C$2.18 a year ago
Recommendations	Ventas price target raised to $58 from $54 at RBC Capital » 06:05 03/02/21 03/02 06:05 03/02/21 06:05 VTR Ventas $52.77 / -0.17 (-0.32%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options VTR Ventas $52.77 / -0.17 (-0.32%) 02/02/21 Ventas appoints Maurice Smith, CEO of HCSC, to board of directors 11/06/20 Ventas, GIC form research & innovation development joint venture VTR Ventas $52.77 / -0.17 (-0.32%) 02/09/21 Mizuho Ventas price target raised to $45 from $38 at Mizuho 01/11/21 BMO Capital Brookdale data supports cautious view on senior housing, says BMO 01/07/21 BMO Capital Ventas downgraded to Underperform from Market Perform at BMO Capital 01/05/21 Baird Healthpeak assumed with an Outperform at Baird VTR Ventas $52.77 / -0.17 (-0.32%) 02/18/21 Ventas sees Q1 FFO 66c-71c, consensus 72c 02/18/21 Ventas reports Q4 FFO 83c, consensus 73c 11/06/20 Ventas reports Q3 normalized FFO 75c, consensus 72c VTR Ventas $52.77 / -0.17 (-0.32%) 11/09/20 Early notable gainers among liquid option names on November 9th

Events

Earnings calls, analyst events, roadshows and more

AMADY
Today at 07:30

Amadeus IT Group - AMADY Conference Calls
SE
Today at 07:30

Sea Limited - SE Conference Calls
FOE
Today at 08:00

Ferro - FOE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
MBI
Today at 08:00

MBIA - MBI Conference Calls
CHS
Today at 08:00

Chico's - CHS Conference Calls
TILE
Today at 08:00

Interface - TILE Conference Calls
LL
Today at 08:00

Lumber Liquidators - LL Conference Calls
IGT
Today at 08:00

International Game - IGT Conference Calls
FSK
Today at 08:00

FS KKR Capital - FSK Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan $124.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley $11.88-12.00 30M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs $30.60 7M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Evercore ISI upgrades C-Corp lodging laggard Marriott to Outperform

TODAY'S FREE FLY STORIES

Get Full Fly Access